New eye scanner may spot blindness risk years earlier
NCT ID NCT02395757
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a device called MAIA, which measures light sensitivity in the retina, can predict when intermediate age-related macular degeneration (AMD) progresses to the advanced stage. Researchers followed 182 people who already had advanced AMD in one eye and intermediate AMD in the other. The goal was to see if microperimetry could catch early warning signs before vision loss occurs, allowing for earlier treatment and better outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could allow doctors to detect AMD progression earlier and start treatment sooner to preserve vision.
What could go wrong
This is an observational study, not a treatment trial. The device may not reliably predict progression, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE 3 AGE RELATED MACULAR DEGENERATION (AREDS CLASSIFICATION) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospice Civils de Lyon
Lyon, 69000, France